A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma
Pelabresib (CPI-0610)(一种 BET 蛋白的小分子抑制剂)在复发或难治性淋巴瘤患者中的 I 期研究
期刊:Cancer Research Communications
影响因子:2
doi:10.1158/2767-9764.CRC-22-0060
Kristie A Blum, Jeffrey G Supko, Michael B Maris, Ian W Flinn, Andre Goy, Anas Younes, Suresh Bobba, Adrian M Senderowicz, Sergey Efuni, Ronda Rippley, Gozde Colak, Patrick Trojer, Jeremy S Abramson